JPRN-UMIN000006362已完成未知
Maintenance therapy with bacillus Calmette-Guérin Connaught stain for non-muscle invasive bladder cancer after transurethral resection: prospective study with low-dose instillation. - Maintenance therapy with bacillus Calmette-Guérin Connaught stain for non-muscle invasive bladder cancer after transurethral resection: prospective study with low-dose instillation.
Graguate school of Medicine, Yamaguchi University0 个研究点目标入组 30 人开始时间: 2011年9月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 Patients who have current or previous upper tract tumor. 2 Patients whose bladder volume is less than 100 ml, which is mesured by uktrasonography. 3 Patients who suffered with urinary frequency (OAB symptom score<=6) 4 Patients who received BCG theraphy previously. 5 Patients who have contraindication of BCG.
研究者
相似试验
招募中
不适用
To study the effect of BCG vaccine in Reducing the Incidence and severity of COVID-19 in the high-risk populatioCTRI/2020/07/026668Indian Council of Medical Research
已完成
不适用
Control Group and Maintenance Treatment with Bacillus Calmette-Guerin for Superficial Bladder Cancer: A Prospective Randomized Trialsuperficial bladder cancer, carcinoma in situ (CIS)JPRN-C000000292Oita BCG study group110
尚未招募
不适用
Therapeutic effect of Intravesical Bacillus Calmette-Guerin(IMMUCYST) to nonmuscle-invasive urothelial carcinoma of bladder and examination of safetybladder cancerJPRN-UMIN000004672niversity of Kobe,Graduate school of medicine100
已完成
3 期
Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and SeveritySARS-CoV-2 InfectionNCT04439045University Health Network, Toronto122
已完成
不适用
Preventive antibacterial short-term therapy in patients with acute ischemic infarction in the territory of the middle cerebral artery (MCA)Circulatory SystemStrokeISRCTN74386719Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)80